Table 2.

MicroRNAs with the most significantly different levels in cerebrospinal fluid of glioblastoma patients in comparison to controls (p < 0.001) supplemented with additional miRNAs tested in the validation phase of the study listed at the bottom of the table (in italics). All miRNAs selected for the validation phase are in bold; and logFC = binary logarithm of Fold Change.

Genes	logFC	Average Expression	p-Value	Adjusted p-Value
miR-196a-5p	4.22	9.76	<0.00001	<0.00001
miR-4306	3.99	1.75	<0.00001	<0.00001
miR-10a-5p	2.64	14.78	<0.00001	<0.00001
miR-4791	−4.01	3.37	<0.00001	<0.00001
miR-30c-5p	−2.20	7.87	<0.00001	<0.00001
miR-1255b-5p	3.18	1.41	<0.00001	<0.00001
miR-30e-5p	−1.21	10.67	<0.00001	<0.00001
miR-549a	4.06	3.71	<0.00001	<0.00001
miR-10b-5p	2.21	16.15	<0.00001	<0.00001
miR-196b-5p	3.76	5.32	<0.00001	<0.00001
miR-199b-3p	1.53	14.09	<0.00001	<0.00001
miR-127-3p	−1.79	7.98	<0.00001	0.00027
let-7b-5p	1.13	17.84	<0.00001	0.00011
miR-574-5p	1.45	10.21	<0.00001	0.00027
miR-152-3p	1.39	10.42	<0.00001	0.00027
miR-1247-3p	2.43	0.43	<0.00001	0.00033
miR-944	3.55	3.33	<0.00001	0.00033
let-7c-5p	1.22	15.75	<0.00001	0.00022
miR-224-5p	3.05	2.21	<0.00001	0.00039
miR-4454	−3.39	5.10	<0.00001	0.00039
miR-335-5p	3.38	4.92	<0.00001	0.00039
miR-17-3p	2.84	2.29	<0.00001	0.00039
miR-365b-5p	2.96	1.62	<0.00001	0.00059
miR-10b-3p	3.10	2.45	<0.00001	0.00072
miR-10a-3p	3.71	4.25	<0.00001	0.00078
miR-140-5p	1.89	4.77	0.01080	0.05594
miR-21-3p	1.14	1.97	0.11732	0.27104